NorthWest Biotherapeutics Inc (NWBO)

[JRIII]

Assuming the company has a communications strategy – which is a stretch, I know – this article could be a strategic "plant" to let investors know not to expect the unblinded results for a couple of months, raise optimism about FDA approval, and to set the stage for the next dilution. Highly speculative, I know, but not crazy. I spent my career in corporate communications and this is the type of thing we would do all the time, because it works. In NWBO's case, though, any type of strategic communications would be a first.